Company: BDRX
Filing Date: 2025-12-11
Form Type: F-1/A
Source: 0001214659-25-017944
Chunk: 159

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-11
Form: F-1/A
Chunk 159
---
 | Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer |     |                   |
| *                     |     | Non-Executive Chairman of the Board                                                       |     | December 11, 2025 |
| Stephen Parker        |     |                                                                                           |     |                   |
| *                     |     | Senior Independent Non-Executive Director                                                 |     | December 11, 2025 |
| Simon Turton, Ph.D.   |     |                                                                                           |     |                   |
| *                     |     | Non-Executive Director                                                                    |     | December 11, 2025 |
| Sijmen de Vries, M.D. |     |                                                                                           |     |                   |
| *                     |     | Non-Executive Director                                                                    |     | December 11, 2025 |
| Ann Merchant          
 *By: /s/Stephen Stamp 
 Stephen Stamp         
 Attorney-in-fact      |     |                                                                                           |     |                   |

| II-5 |

<div align='center'>AUTHORIZED REPRESENTATIVE</div>

Pursuant to the requirements
of the Securities Act of 1933, as amended, this Registration Statement on Form F-1 has been signed by the undersigned on this 11th day
of December, 2025.

| By:    | /s/ Donald J. Puglisi                          |
| Name:  | Donald J. Puglisi                              |
| Title: | Authorized Representative in the United States |

| II-6 |

<div align='center'>Exhibit Index</div>

| Exhibit 
 Number  
 3.1     
 4.1     |     | Title                                                                                                                                                                                                                                                                                                                                                                                         
 Articles of Association of Biodexa Pharmaceuticals PLC, adopted on June 11, 2025 (incorporated by reference to Exhibit 1.1 to the Company’s Report on Form 6-K, filed with the SEC on June 13, 2025).                                                                                                                                                                                         
 Description of Securities Registered Under Section 12 of the Exchange Act (incorporated by reference to Exhibit 2.1 to the Company’s Annual Report on Form 20-F, filed with the SEC on April 11, 2025).                                                                                                                                                                                       |
|:--------|:----|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.2     |     | Specimen certificate representing ordinary shares of Biodexa Pharmaceuticals Plc (incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form F